Ataluren, formerly known as PTC124, is a small-molecular agent designed by PTC Therapeutics and sold under the trade name Translarna in the European Union.
Ataluren is a small-molecular agent designed by PTC Therapeutics and sold under the trade name Translarna in the European Union. Ataluren is formerly known as PTC124.